Ignite Creation Date:
2024-05-06 @ 12:23 PM
Last Modification Date:
2024-10-26 @ 12:58 PM
Study NCT ID:
NCT03746912
Status:
NO_LONGER_AVAILABLE
Last Update Posted:
2020-04-15
First Post:
2018-11-15
Brief Title:
Expanded Treatment Protocol for Adults With FLT3-ITD Mutated Relapsed or Refractory Acute Myeloid Leukemia AML to Receive Quizartinib
Sponsor:
Daiichi Sankyo
Organization:
Daiichi Sankyo
Organization Data
Organization:
Daiichi Sankyo
Class:
INDUSTRY
Study ID:
AC220-A-U203
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Daiichi Sankyo
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None